LYSOPAÏNE MAUX DE GORGE AMBROXOL MENTHE 20 mg sugar-free, lozenge sweetened with sorbitol and with sodium saccharin 18 lozenges
Active ingredients: Ambroxol hydrochloride
Commercialized according to BDPM
Lozenge18 lozengesvoie buccale autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LYSOPAÏNE MAUX DE GORGE AMBROXOL MENTHE 20 mg SANS SUCRE, pastille édulcorée au sorbitol et à la saccharine sodique
- Pharmaceutical form
- pastille
- Route of administration
- voie buccale autre
- Presentation description
- plaquette(s) thermoformée(s) polypropylène aluminium de 18 pastille(s)
- Marketing authorisation holder
- OPELLA HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 17 Feb 2025
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69795608CIP74998372CIP133400949983728Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'AMBROXOLpastille | 20 mg · une pastille | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.